SINOVAC BIOTECH LTD Debt Securities, Available-for-sale, Amortized Cost
SINOVAC BIOTECH LTD (SVA) had Debt Securities, Available-for-sale, Amortized Cost of $113.28 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-06-05
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $113.28M.
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $2.14B.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $1.16B.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $416.11M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2025-12-31 | $113.28M 20-F · filed 2026-06-05 |
| 2024-12-31 | $2.14B 20-F · filed 2026-06-05 |
| 2023-12-31 | $1.16B 20-F · filed 2026-04-30 |
| 2022-12-31 | $416.11M 20-F · filed 2026-04-30 |
| 2021-12-31 | $0.00 20-F · filed 2026-04-30 |